About
Alleviant Medical is a clinical-stage medical device company founded in 2017, dedicated to developing innovative, minimally invasive therapies for patients with chronic heart failure. The company's flagship product, the Alleviant System, is an investigational, no-implant interatrial shunt device designed to create a temporary connection between the left and right atrial chambers of the heart. This connection aims to alleviate excess pressure in the heart, addressing symptoms like shortness of breath and fatigue. The Alleviant System is currently undergoing clinical evaluation in pivotal trials, including the ALLAY-HF and ALLAY-HFrEF studies, with FDA approval and breakthrough device designation supporting its development. The company has completed first-in-human and animal studies and is actively enrolling patients to demonstrate the device's safety and efficacy. Alleviant Medical's mission is to enhance heart failure care and improve the quality of life for millions of patients worldwide.
Technologies
Keywords
Company Information
-
Employees 55
-
Founded 2017
-
Annual Revenue $4500000
-
Total Funding $186365983
Location
7801 N Lamar Blvd, Austin, Texas, United States, 78752